Outsourced Pharma Capacity Update July 2025 – Small Molecule
Upperton Shortlisted for Two Categories at the Pharma Industry Awards UK 2025
We’re delighted to have been shortlisted in two major categories at the Pharma Industry Awards UK 2025, recognising our growth.
Biologics vs Small Molecules: Key Considerations in Drug Development
How the body absorbs, distributes, metabolizes, and excretes a drug – differs significantly between the two modalities.
CDMO Services for Finished Dosage Forms (FDF): Formulation, Development, and Manufacturing
Discover how CDMO services support Finished Dosage Form (FDF) development, from formulation to manufacturing and regulatory compliance.
Webinar – Navigating the Sterile Fill Finish CDMO Landscape for Development & Manufacturing Success
Upperton Pharma Solutions Wins Business Expansion Award at the 2025 Pharmaceutical Technology Excellence Awards
We’re delighted to announce that we’ve won the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.
Product Considerations in Sterile Drug Formulation Development
Discover the critical product decisions in sterile drug formulation development. Learn how planning with your CDMO can streamline your path.
On-Demand Webinar – Navigating the sterile fill finish CDMO landscape
Nikki Whitfield, CEO of Upperton Pharma Solutions, Honoured with ‘CEO Excellence in Pharmaceutical Manufacturing’ Award at the CEO Today Global Awards 2025.
Nikki Whitfield, CEO of Upperton, has received the ‘CEO Excellence in Pharmaceutical Manufacturing’ Award at the CEO Today Global Awards 2025
Upperton Continues Strategic Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.
Upperton continues growth with appointment of Michael Mellor-Clark as Chief Commercial Officer.